Followed by Keytruda, Opdivo completed in landing into ‘Big 5’ hospitals
‘Opdivo,’ an immunotherapy cooperated by BMS and Ono Pharmaceutical, entered Seoul National University Hospital, completing the landing process into the ‘Big 5’ hospitals.
According to the industry concerned on the 26th, Seoul National University Hospital pushed through 9 drugs including Opdivo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
